JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, G.-F.
Right arrow Articles by Badger, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, G.-F.
Right arrow Articles by Badger, T. M.

Vol. 283, Issue 3, 1486-1494, 1997

Hormonal Regulation of Microsomal Cytochrome P450 2C11 in Rat Liver and Kidney1

Gen-Fu Chen, Martin J. J. Ronis, Paul E. Thomas, David J. Flint and Thomas M. Badger

Department of Pediatrics (G.-F.C., M.J.J.R., T.M.B.), University of Arkansas for Medical Sciences, Arkansas Children's Hospital Research Institute, Little Rock, Arkansas; Rutgers College of Pharmacy (P.E.T.), Rutgers, New Jersey; and Hannah Research Institute (D.J.F.), Ayr KA6 5HL, Scotland

The current study was conducted to investigate hormonal regulation of cytochrome P450 2C11 (CYP2C11) in rat liver and kidney of adult male rats. In two experiments, hypophysectomy (Hx) resulted in decreased (P < .05) hepatic CYP2C11 apoprotein and mRNA levels. Growth hormone (GH) replacement of Hx rats prevented the decline in hepatic CYP2C11 apoprotein and mRNA levels, whereas, subcutaneous injection of testosterone had no effect. Rat pituitary extract is equally effective in intact or castrated Hx rats in preventing the decline in hepatic CYP2C11 apoprotein and mRNA levels. Specific neutralization of rat GH by sheep anti-rat GH serum reduced (P < .05) serum IGF-I concentrations, hepatic CYP2C11 apoprotein and mRNA levels. Hx of male rat resulted in decreased (P < .05) renal CYP2C11 apoprotein and mRNA levels, and treatment with GH failed to prevent these effects; however, supplementation of Hx rats with testosterone or rat pituitary extract prevented the Hx-induced decrease of renal CYP2C11 apoprotein and mRNA levels, and the effects of rat pituitary extract occurred only in intact rats. Neutralization of rat GH by anti-rGH significantly reduced (P < .05) CYP2C11 mRNA levels and serum T concentrations but not serum LH concentrations. These results indicate that although hepatic CYP2C11 is regulated by GH, rat renal CYP2C11 is regulated primarily by gonadal steroids.

0022-3565/97/2833-1486$03.00/0
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. Rahmaniyan, K. Patrick, and N. H. Bell
Characterization of recombinant CYP2C11: a vitamin D 25-hydroxylase and 24-hydroxylase
Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E753 - E760.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. M. Badger, M. J. J. Ronis, S. J. Frank, Y. Chen, and L. He
Effects of Chronic Ethanol on Hepatic and Renal CYP2C11 in the Male Rat: Interactions with the Janus-Kinase 2-Signal Transducer and Activators of Transcription Proteins 5b Pathway
Endocrinology, September 1, 2003; 144(9): 3969 - 3976.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
M. J. J. Ronis, J. Aronson, G. G. Gao, W. Hogue, R. A. Skinner, T. M. Badger, and C. K. Lumpkin Jr.
Skeletal Effects of Developmental Lead Exposure in Rats
Toxicol. Sci., August 1, 2001; 62(2): 321 - 329.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.